Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Weight Loss 2Stomach Neoplasms 2Malnutrition 2Esophageal Neoplasms 2Pituitary Neoplasms 1Periampullary Tumors 1Pancreatic Neuroendocrine Tumor G2 1Pancreatic Neoplasms 1Lymphocele 1Endocrine System Diseases 1Duodenal Neoplasms 1Breast Neoplasms 1Acromegaly 1

Interventions

Pancreaticojejunostomy 2Stents 1Sodium Chloride 1Octreotide 1Nutrition Therapy 1Dietary Supplements 1Anti-Bacterial Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Duodenal Neoplasms × Octreotide × Clear all
NCT02381249 2023-11-27

The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery

St. James's Hospital, Ireland

Phase NA Completed
40 enrolled
Gastrointestinal

Duodenal Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Weight Loss, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡